Compile Data Set for Download or QSAR
Report error Found 78 Enz. Inhib. hit(s) with all data for entry = 9633
TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477131(US10888567, Compound 42 | US20250186410, Compound ...)
Affinity DataIC50: 1.00E+3nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477158(US10888567, Compound 67 | US20250186410, Compound ...)
Affinity DataIC50: 1.00E+3nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477156(US10888567, Compound 66 | US20250186410, Compound ...)
Affinity DataIC50: 1.00E+3nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477136(US10888567, Compound 47 | US20250186410, Compound ...)
Affinity DataIC50: 1.00E+3nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477107(US10888567, Compound 3 | US11414428, Compound 1 | ...)
Affinity DataIC50: 5.50E+3nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477105(US10888567, Compound 1 | US20250186410, Compound 1)
Affinity DataIC50: 5.50E+3nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477122(US10888567, Compound 16 | US20250186410, Compound ...)
Affinity DataIC50: 5.50E+3nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477138(US10888567, Compound 49 | US20250186410, Compound ...)
Affinity DataIC50: 5.50E+3nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477116(US10888567, Compound 11 | US20250186410, Compound ...)
Affinity DataIC50: 5.50E+3nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477114(US10888567, Compound 9 | US20250186410, Compound 9)
Affinity DataIC50: 5.50E+4nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477113(US10888567, Compound 8 | US20250186410, Compound 8)
Affinity DataIC50: 5.50E+4nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477111(US10888567, Compound 6 | US20250186410, Compound 6)
Affinity DataIC50: 5.50E+4nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477110(US10888567, Compound 5 | US20250186410, Compound 5)
Affinity DataIC50: 5.50E+4nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477109(US10888567, Compound 4 | US20250186410, Compound 4)
Affinity DataIC50: 5.50E+4nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477178(US10888567, Compound 84 | US20250186410, Compound ...)
Affinity DataIC50: 5.50E+4nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477139(US10888567, Compound 50)
Affinity DataIC50: 5.50E+4nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477171(US10888567, Compound 79)
Affinity DataIC50: 5.50E+4nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477167(US10888567, Compound 75)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477166(US10888567, Compound 74 | US20250186410, Compound ...)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477165(US10888567, Compound 73)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477164(US10888567, Compound 72)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477163(US10888567, Compound 71)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477162(US10888567, Compound 70)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477161(US10888567, Compound 69)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477159(US10888567, Compound 68)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477155(US10888567, Compound 65)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477153(US10888567, Compound 64)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477152(US10888567, Compound 63)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477151(US10888567, Compound 62)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477150(US10888567, Compound 61)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477149(US10888567, Compound 60)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477185(US10888567, Compound 91)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477184(US10888567, Compound 90)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477183(US10888567, Compound 89 | US20250186410, Compound ...)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477182(US10888567, Compound 88)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477181(US10888567, Compound 87)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477180(US10888567, Compound 86)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477179(US10888567, Compound 85)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477177(US10888567, Compound 83)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477175(US10888567, Compound 82)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477174(US10888567, Compound 81)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477173(US10888567, Compound 80)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477170(US10888567, Compound 78)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477169(US10888567, Compound 77)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477168(US10888567, Compound 76)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477190(US10888567, Compound 96)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477189(US10888567, Compound 95 | US20250186410, Compound ...)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477188(US10888567, Compound 94)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477187(US10888567, Compound 93)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandPNGBDBM477186(US10888567, Compound 92)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent

Displayed 1 to 50 (of 78 total ) | Next | Last >>
Jump to: